M
Marrone Bio Innovations
Pesticide company developing natural products for weed, pest, and plant disease management
About Marrone Bio Innovations
Marrone Bio Innovations (MBI) was an agricultural technology company focused on the discovery, development, and sale of biologically-based products for pest management and plant health. The company was founded in 2006 by Dr. Pamela Marrone, a serial entrepreneur in the agricultural biotechnology space. Her journey in this field began with a childhood fascination with entomology after seeing caterpillar infestations destroy trees. This passion led her to earn a B.S. in Entomology from Cornell University and a Ph.D. in the same field from North Carolina State University. Before founding MBI, Dr. Marrone started her career at Monsanto, founded Entotech Inc. for Novo Nordisk, and established AgraQuest, which was later acquired by Bayer Crop Science.
MBI targeted the agricultural sector, serving growers of specialty crops like fruits, nuts, and vegetables, as well as row crops and the turf and ornamental markets. The company's business model revolved around creating environmentally responsible alternatives to conventional chemical pesticides. Revenue was generated through the sale of its portfolio of proprietary products. The company's research and development program screened thousands of naturally occurring microorganisms and plant extracts to create its solutions, which were supported by a portfolio of over 500 issued and pending patents.
The product lineup included biofungicides, bioinsecticides, and bionematicides. Key products included REGALIA®, a plant extract-based biofungicide that promotes plant health, and GRANDEVO® and VENERATE®, which are microbial-based insecticides. Another product, Zequanox®, was developed to control invasive zebra and quagga mussels in water systems. These products offered growers a way to manage pests and diseases, potentially increase yields, and reduce the environmental load of chemical residues.
A significant milestone for MBI was its initial public offering on the NASDAQ stock exchange (as MBII) on August 2, 2013. In 2019, the company expanded its offerings by acquiring Pro Farm Technologies OY, a Finnish company specializing in nutrient and biostimulant products for seed and foliar treatments. However, the company also faced challenges, including an accounting scandal in 2016 that led to a restatement of financial results and a penalty. Dr. Marrone retired as CEO in 2020. In July 2022, Marrone Bio Innovations was acquired by the Argentinian firm Bioceres Crop Solutions in an all-stock transaction valued at approximately $236 million, combining the two companies' portfolios to create a larger entity in sustainable agricultural solutions. Following the merger, MBI was set to continue its operations as a wholly-owned subsidiary of Bioceres under the name ProFarm.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2013
- Employees
- 154
- Open positions
- 1
- Dealroom signal
- 59.3/100
- Industry
- Food
- Sub-industry
- AgriTech
- Sector
- Biotechnology, Non-Invasive medical devices and treatments, Biotech and Pharma, Biotechnology in Food, Hard Tech, DT and LS, science-based
- Client focus
- B2B
- Investment activity
- 1 company, latest Aug 2019
- Capital deployed
- —
- Preferred round
- ACQUISITION
News
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Mar 2022 | $236M | $236M | Bioceres Crop Solutions | ↗ |
| POST IPO EQUITYOther financing | Feb 2018 | $30M | — | Ospraie Ag Science | — |
Growth signals
Latest recorded traffic for Marrone Bio Innovations is 560 monthly website visits, up 93.1% over the last three months. Marrone Bio Innovations's team grew 0% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Marrone Bio Innovations in the Davis ecosystem
The Marrone Bio Innovations office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
Clean Pacific Ventures
Saffron Hill Ventures
Calvert Research and Management
Valley Oak Investments
Wavepoint Ventures- OCOne Earth Capital
- SPStuart Mill Venture Partners
Series B and later5 investors entered at this stage
Syngenta Ventures- TGThe Contrarian Group
Mitsui Global Investment
Point Financial
Ospraie Ag Science
Other known investors6 additional known investors
Bioceres Crop Solutions
Checkmate Capital- CGCheckmate Capital Group
Syngenta Group Ventures
US Department of Agriculture
Van Herk Investments
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Marrone Bio Innovations on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Marrone Bio Innovations’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.











